Access cutting-edge plaque psoriasis treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.
Access plaque psoriasis specialists in Aurora at no cost
This study follows strict safety protocols and ethical guidelines
All study-related plaque psoriasis treatment provided free
The purpose of the study is to evaluate the pharmacokinetic (PK) of certolizumab pegol (CZP) in study participants aged 6 to 17 years with moderate to severe chronic plaque psoriasis (PSO) in order to support extrapolation of efficacy.
Sponsor: UCB Biopharma SRL
Check if you qualify for this plaque psoriasis clinical trial in Aurora, CO
If you're searching for plaque psoriasis treatment options in Aurora, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced plaque psoriasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.